Eight Pharmaceutical Leaders Initiate New Company To Manage And Promote Digital Identity Assurance Standard Across The Biopharmaceutical Industry

Eight global pharmaceutical organizations, including AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer Inc., Procter & Gamble and Sanofi-Aventis have come together as the founding members to form SAFE–BioPharma, LLC, a not-for-profit limited liability company, to support widespread adoption of the global digital identity standard, Secure Access for Everyone - SAFE. SAFE-BioPharma, LLC will establish and maintain the standards and operating rules for the provisioning and management of digital credentials that will be used in electronic clinical research records between the biopharmaceutical industry and government regulatory agencies globally. As an industry initiative, SAFE-BioPharma, LLC, will continue to encourage other biopharmaceutical companies of all sizes to join the organization and leverage the standard. Amgen Inc. has also agreed to be a member of the newly incorporated company.

Back to news